Anthony D. Kang

2.2k total citations · 1 hit paper
18 papers, 1.7k citations indexed

About

Anthony D. Kang is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Anthony D. Kang has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Immunology. Recurrent topics in Anthony D. Kang's work include Fibroblast Growth Factor Research (2 papers), Reproductive tract infections research (2 papers) and Antibiotic Resistance in Bacteria (2 papers). Anthony D. Kang is often cited by papers focused on Fibroblast Growth Factor Research (2 papers), Reproductive tract infections research (2 papers) and Antibiotic Resistance in Bacteria (2 papers). Anthony D. Kang collaborates with scholars based in United States and South Korea. Anthony D. Kang's co-authors include François Paris, Desiree Ehleiter, Adriana Haimovitz‐Friedman, Zvi Fuks, Paola Capodieci, Carlos Cordon‐Cardo, Richard Kolesnick, Gloria Juan, Kenny Smith and James E. Kirby and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Anthony D. Kang

18 papers receiving 1.6k citations

Hit Papers

Endothelial Apoptosis as the Primary Lesion Initiating In... 2001 2026 2009 2017 2001 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony D. Kang United States 14 565 536 353 290 206 18 1.7k
Jonathan F. Head United States 25 508 0.9× 504 0.9× 371 1.1× 127 0.4× 150 0.7× 69 1.7k
Philip M. Carpenter United States 26 1.3k 2.2× 482 0.9× 652 1.8× 495 1.7× 64 0.3× 73 3.3k
Weiping Zeng United States 21 780 1.4× 320 0.6× 579 1.6× 114 0.4× 145 0.7× 51 1.8k
Eyal Fenig Israel 33 736 1.3× 208 0.4× 1.3k 3.6× 366 1.3× 69 0.3× 118 2.8k
Yan Jia China 25 1.0k 1.8× 242 0.5× 405 1.1× 226 0.8× 61 0.3× 89 1.8k
Andreas S. Barth United States 31 1.3k 2.3× 171 0.3× 686 1.9× 176 0.6× 51 0.2× 81 3.0k
Takeshi Tamaki Japan 23 453 0.8× 159 0.3× 326 0.9× 224 0.8× 48 0.2× 94 1.8k
Zhen Han China 23 560 1.0× 247 0.5× 390 1.1× 407 1.4× 40 0.2× 40 1.6k

Countries citing papers authored by Anthony D. Kang

Since Specialization
Citations

This map shows the geographic impact of Anthony D. Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony D. Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony D. Kang more than expected).

Fields of papers citing papers by Anthony D. Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony D. Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony D. Kang. The network helps show where Anthony D. Kang may publish in the future.

Co-authorship network of co-authors of Anthony D. Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony D. Kang. A scholar is included among the top collaborators of Anthony D. Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony D. Kang. Anthony D. Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Morgan, Christopher E., Yoon‐Suk Kang, Kenny Smith, et al.. (2023). Streptothricin F is a bactericidal antibiotic effective against highly drug-resistant gram-negative bacteria that interacts with the 30S subunit of the 70S ribosome. PLoS Biology. 21(5). e3002091–e3002091. 15 indexed citations
2.
Clifton, Guy T., Florian Krammer, Eric D. Laing, et al.. (2021). SARS-CoV-2 Infection Risk Among Active Duty Military Members Deployed to a Field Hospital — New York City, April 2020. MMWR Morbidity and Mortality Weekly Report. 70(9). 308–311. 8 indexed citations
3.
Kang, Anthony D., et al.. (2020). Evaluation of the fully automated AIX1000 rapid plasma reagin system compared to a manual plasma reagin testing method for the diagnosis of syphilis. Diagnostic Microbiology and Infectious Disease. 97(4). 115081–115081. 5 indexed citations
4.
Riedel, Stefan, et al.. (2019). Evaluation of apramycin against spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae. Journal of Antimicrobial Chemotherapy. 74(5). 1311–1316. 25 indexed citations
5.
Kang, Anthony D., Kenny Smith, Anders H. Berg, et al.. (2018). Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh Model. Antimicrobial Agents and Chemotherapy. 62(4). 27 indexed citations
6.
Kang, Anthony D., Kenny Smith, George M. Eliopoulos, et al.. (2017). In vitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Diagnostic Microbiology and Infectious Disease. 88(2). 188–191. 56 indexed citations
7.
Smith, Kenny, Anthony D. Kang, & James E. Kirby. (2017). Automated Interpretation of Blood Culture Gram Stains by Use of a Deep Convolutional Neural Network. Journal of Clinical Microbiology. 56(3). 99 indexed citations
8.
Kang, Anthony D., et al.. (2013). ON01210.Na (Ex-RAD®) Mitigates Radiation Damage through Activation of the AKT Pathway. PLoS ONE. 8(3). e58355–e58355. 36 indexed citations
9.
Pishvaian, Michael J., Geeta Upadhyay, Zhixing Yao, et al.. (2008). CDK4 is an important target for hepatocellular cancer with inactivation of TGF-beta signaling through Smad and ELF. Cancer Research. 68. 2583–2583. 2 indexed citations
10.
Reddy, M. V. Ramana, Muralidhar R. Mallireddigari, Stephen C. Cosenza, et al.. (2007). Design, Synthesis, and Biological Evaluation of (E)-Styrylbenzylsulfones as Novel Anticancer Agents. Journal of Medicinal Chemistry. 51(1). 86–100. 46 indexed citations
11.
Gumireddy, Kiranmai, Stacey J. Baker, Stephen C. Cosenza, et al.. (2005). A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance. Proceedings of the National Academy of Sciences. 102(6). 1992–1997. 172 indexed citations
12.
Kang, Anthony D., Gyeongsin Park, Yeul Hong Kim, & Il‐Hoan Oh. (2004). Differential modulation of Myb family genes by Ets-2. Oncogene. 23(23). 4177–4181. 1 indexed citations
13.
Mangan, James K., Sushil G. Rane, Anthony D. Kang, et al.. (2004). Mechanisms associated with IL-6–induced up-regulation of Jak3 and its role in monocytic differentiation. Blood. 103(11). 4093–4101. 27 indexed citations
14.
Lee, Kyoung‐Jin, et al.. (2003). Evaluation of Critical Formulation Factors in the Development of a Rapidly Dispersing Captopril Oral Dosage Form. Drug Development and Industrial Pharmacy. 29(9). 967–979. 53 indexed citations
15.
Paris, François, Zvi Fuks, Anthony D. Kang, et al.. (2001). Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice. Science. 293(5528). 293–297. 1023 indexed citations breakdown →
16.
Kang, Anthony D., Hong Chen, Quan Yuan, et al.. (1999). Lpsd/Ran of endotoxin-resistant C3H/HeJ mice is defective in mediating lipopolysaccharide endotoxin responses. Proceedings of the National Academy of Sciences. 96(20). 11543–11548. 43 indexed citations
17.
Le, Quan, René Daniel, Anthony D. Kang, et al.. (1998). Involvement of C-Abl Tyrosine Kinase in Lipopolysaccharide- Induced Macrophage Activation. The Journal of Immunology. 160(7). 3330–3336. 22 indexed citations
18.
Kang, Anthony D., et al.. (1996). Restoration of lipopolysaccharide-mediated B-cell response after expression of a cDNA encoding a GTP-binding protein. Infection and Immunity. 64(11). 4612–4617. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026